EN DE

Ami Organics Limited (AMIORG) Fair Value & Analysis

Basic Materials · IN · Market cap ₹96.3B

AO Ami Organics Limited AMIORG · BSE
Price₹3,111
Fair Value₹269.07
Upside-91.4%
Quality41/100
Watch Ami Organics Limited for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Solidly profitable · 15.8% net margin
Low debt · negative free cash flow
0.13% dividend yield
Mixed vs. peers (6/13)
Wide moat 68/100
Evidence: High Range ₹201.81 – ₹336.34 Share as image

Fair value as of: Aug 13, 2026

From 16 valuation models · updated today

Share price −15.7% over the past month.

Below-average quality, and screening another 91% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (₹336.34). The favourable scenario is already priced in.
  • Weak quality (41/100) and above fair value at the same time, the margin of safety is missing on both counts.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

₹3,691 ₹397.25 Fair Value ₹269.07 Sep 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

59‑month range ₹397.25 – ₹3,691 · fair‑value band ₹201.81 – ₹336.34 · the ₹3,111 price screens above the ₹269.07 fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Ami Organics Limited (AMIORG) currently trades at ₹3,111, while our model-based Fair Value estimate is ₹269.07, implying the stock looks roughly 91.4% overvalued today. The Quality Score stands at 41/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Ami Organics Limited generated revenue of ₹10.1B at a net margin of 15.8%. Revenue grew 37.1% year over year. It earns a return on equity of 16.0%. Net debt stands at ₹1.9B. Fundamentals as of Aug 13, 2026

Our scenario range runs from ₹201.81 (bear case) to ₹336.34 (bull case); at ₹3,111, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 17% below its 52-week high and 183% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -68% fair-value upside, at -91%, AMIORG screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Note: the current price implies far more future growth than the conservative anchors of our models allow (base growth is deliberately capped, we do not regard such extreme rates as sustainable). Our models are not designed for expectations this high; that is why the individual models scatter extremely (₹24.14 to ₹929.21). Read the values as a conservative anchor, not as a price target.
Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income ₹148.77 ₹182.19 ₹467.86 76
ROIC Compounder ₹314.11 ₹457.63 ₹565.91 72
Gordon GGM ₹13.77 ₹28.63 ₹45.42 70
All 16 models by family
Earnings-Based
Graham-Dodd ₹133.24 ₹929.21 ₹1,304 54
Lynch FV ₹467.99 ₹668.56 ₹869.13 50
PEG = 1.0 ₹467.99 ₹668.56 ₹869.13 46
EPV ₹237.73 ₹273.58 ₹304.95 59
Dividend Discount
Gordon GGM ₹13.77 ₹28.63 ₹45.42 70
DDM Multi-Stage ₹13.77 ₹24.14 ₹30.05 61
Multiples
P/E Multiple ₹249.83 ₹333.11 ₹416.38 63
P/S Multiple ₹138.36 ₹184.48 ₹230.60 58
P/B Multiple ₹249.83 ₹333.11 ₹416.38 55
EV/EBIT ₹286.12 ₹373.96 ₹461.79 53
EV/EBITDA ₹235.23 ₹306.09 ₹376.96 54
EV/Revenue ₹151.76 ₹207.10 ₹262.45 43
Asset-Based
NCAV (Graham) ₹79.98 ₹107.18 ₹159.97 50
Economic Profit
Residual Income ₹148.77 ₹182.19 ₹467.86 76
ROIC Compounder ₹314.11 ₹457.63 ₹565.91 72
Growth Earnings
Growth-Adj P/E ₹578.11 ₹825.87 ₹1,074 68

Widest divergence: Growth Earnings (₹825.87) versus Dividend Discount (₹24.14). Highest evidence: Residual Income (76).

Notify me when AMIORG reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) ₹10.1B
Revenue growth (YoY) +37.1%
Net margin 15.8%
Return on equity 16.0%
Free cash flow −₹763M FY2025
P/E ratio 119.0 as of Jul 5, 2026
More key figures
Operating margin 25.2%
EPS (TTM) ₹9.89
Dividend yield 0.1%
EPS growth (YoY) +128%
Net debt ₹1.9B FY2024

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 41/100

Of which business quality 43 · Market factors (momentum, volatility) 87

Profitability 56
Margins and returns on capital today
Quality Growth 70
Are margins and returns improving?
Cashflow 16
Earnings quality: real cash, not paper profit
Fin. Strength 88
Balance sheet, leverage, solvency risk
Investment 1
Disciplined investing over empire-building
Low Volatility 67
Calm price path (market factor)
Momentum 100
Price trend over the last 3–12 months (market factor)
52W Momentum 88
Distance to the 52-week high (market factor)
Net Issuance 0
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Full company description

Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formulation, salicylic acid, and other special chemicals that are used in cosmetics, dyes, polymers and agrochemical, animal foods, and personal care industries. Ami Organics Limited exports its products. The company was founded in 2004 and is based in Surat, India.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Ami Organics Limited reported revenue of ₹10.1B in FY2025 versus ₹3.4B in FY2021, a compound +31.1%/yr. Reported net income was ₹1.6B in FY2025, compounding +31.3%/yr from FY2021.

Growth Quality 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
₹10.1B
Latest YoY
+40.3%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+24.8%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+33.3%
Revenue +31.1%/yr
FY21 ₹3.4B
FY22 ₹5.2B
FY23 ₹6.2B
FY24 ₹7.2B
FY25 ₹10.1B
Net income +31.3%/yr
FY21 ₹540M
FY22 ₹719M
FY23 ₹833M
FY24 ₹487M
FY25 ₹1.6B

AMIORG screens 91% overvalued. Compare with Linde plc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Ami Organics Limited Fair Value". https://www.fairvalue-calculator.com/stock/AMIORG

Peer Group

Specialty Chemicals · 666 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 41 · Bottom 25%
Fair Value upside −91% · Bottom 25%
Return on equity (TTM) 16% · Top 25%
Return on assets 10% · Top 25%
Net margin (TTM) 16% · Top 25%
Operating margin (TTM) 25% · Top 25%
Revenue growth 37% · Top 25%
Dividend yield (TTM) 0.1% · Bottom 25%

Valuation Multiples vs Specialty Chemicals median · lower = cheaper

P/E (TTM) 119.0× · Pricier than 75% of peers
P/B 7.35× · Pricier than 75% of peers
P/S (TTM) 9.57× · Pricier than 75% of peers
EV/EBITDA 40.7× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 100 · sector 18
PAST 64 · sector 23
HEALTH 100 · sector 95
DIVIDEND 3 · sector 25

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN $479.43 $222.03 -54%
Wanhua Chemical Group 600309 ¥75.06 ¥68.03 -9%
Novozymes A/S NSISB kr 416.10 kr 170.02 -59%
Asian Paints Limited ASIANPAINT ₹2,756 ₹664.51 -76%
Solar Industries India Limited SOLARINDS ₹18,730 ₹2,793 -85%
Pidilite Industries Limited PIDILITIND ₹1,702 ₹351.84 -79%
PT Chandra Asri Pacific Tbk TPIA 2,160 IDR 2,322 IDR +8%
Berger Paints India Limited BERGEPAINT ₹559.80 ₹154.46 -72%
Gujarat Fluorochemicals Limited FLUOROCHEM ₹4,566 ₹836.47 -82%
Himadri Speciality Chemical Limited HSCL ₹778.15 ₹248.63 -68%

Compare Ami Organics Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Ami Organics Limited (AMIORG) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of ₹269.07 versus a price of ₹3,111, about −91% (overvalued).
What is the fair value of AMIORG?
Our model-based fair value for Ami Organics Limited is ₹269.07 (as of Aug 13, 2026), built from audited fundamentals. The current price is ₹3,111.
What is the quality score of AMIORG?
Ami Organics Limited has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Ami Organics Limited (AMIORG)?
Ami Organics Limited reported trailing-twelve-month revenue of about ₹10.1B (latest available figure, as of Aug 13, 2026).
What is the net profit margin of AMIORG?
The net profit margin of Ami Organics Limited is about 15.8%, meaning it keeps roughly 15.8% of revenue as net income. Based on the latest reported figures.
Does Ami Organics Limited pay a dividend?
Ami Organics Limited currently shows a dividend yield of about 0.13% relative to its recent price (as of Aug 13, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Ami Organics Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.